Report center

医药生物行业报告：血制品批签发平稳行业有望维持高景气度，政策有望推动院内设备更新提速-中邮证券

血制品批签发平稳行业有望维持高景气度，政策有望推动院内设备更新提速一周观点：血制品批签发整体平稳，行业有望维持高景气度据中检所数据披露统计，2024.01.01-03.10间共有14个血制品产品获批签发，合计签发达1284批次，同比下降11.63%。去年年初疫情放开静丙需求大增，基数较高。批签发与产品供给相关，产品需求端预计持续增长。随着十四五规划浆站的陆续建成落地，我国血浆供给侧有望实现稳定

No subject companies

Publishers

中邮证券 View content →

Suggested next hops

Ranked by edge type and evidence strength (max 5). Prefer these over scrolling the full lists.

Ask about this report neighborhood Read full report →

Other hot industries

Healthcare Services View content →

No related reports

← Back to knowledge graph